HIF1A and neoplasm: Dramatic reductions in spleen, liver, and renal weights and alleviation of spleno-/hepatomegaly on combined treatment with FO/Se and doxorubicin may be attributed to reduction of leukemoid reaction, tumor immune cell infiltration, hypoxia-regulated HIF-1α induction, and tumor invasion in the present study.